-
-
ADALIMUMAB-RYVK(CF) AUTOINJECT (Generic for SIMLANDI(CF) AUTOINJECTOR)
- QTY 2
- 40MG/0.4ML
- AUTOINJKIT
- Near New Richmond, Ohio 45157
ADALIMUMAB (ay da LIM yoo mab) treats autoimmune conditions, such as psoriasis, arthritis, Crohn disease, and ulcerative colitis. It works by slowing down an overactive immune system. It may also be used to treat hidradenitis suppurativa (HS). HS is a condition that causes painful lumps under the skin in areas such as the armpits and groin. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.
Change Location
Set Price Drop Alert for:
ADALIMUMAB-RYVK(CF) AUTOINJECT (Generic for SIMLANDI(CF) AUTOINJECTOR)
- QTY 2
- 40MG/0.4ML
- AUTOINJKIT
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
ADALIMUMAB-RYVK(CF) AUTOINJECT (Generic for SIMLANDI(CF) AUTOINJECTOR)
- QTY 2
- 40MG/0.4ML
- AUTOINJKIT
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
ADALIMUMAB-RYVK(CF) AUTOINJECT (Generic for SIMLANDI(CF) AUTOINJECTOR) Lifestyle Interactions
-
Losartan Potassium 100mg, Oral tablet
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during losartan treatment due to the risk for decreased exposure to the active metabolite of losartan and decreased losartan efficacy. Losartan is converted to a more active metabolite via CYP2C9 and grapefruit juice is a CYP2C9 inhibitor. Coadministration with a moderate CYP2C9 inhibitor in two pharmacokinetic studies with healthy volunteers decreased concentrations of the active metabolite of losartan by 30% to 56%.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
